|
|
|
11-50 employees
View all
|
|
Biotechnology
|
|
1000 Marina Blvd, Brisbane, California 94005, US
|
|
Nitrase Therapeutics is a pioneering biopharmaceutical company deploying its unique NITROME platform to unlock the therapeutic potential of nitrases, a new class of enzymes that it discovered, to develop a pipeline of therapies against a broad variety of diseases. The medicines that Nitrase Therapeutics is developing will target these enzymes and potentially help slow or halt the progression of a wide variety of diseases in which nitrases and nitro-substrates play a role, including Parkinson’s and cancer. Nitrase Therapeutics (under the former name Nitrome Biosciences) has been widely recognized and has won multiple awards including the prestigious Target Advancement grant from The Michael J. Fox Foundation for Parkinson's Research (MJFF).
|
Nitrase Therapeutics Email Formats | Example Email Formats | Percentage |
---|---|---|
{f}{last} | [email protected] |
75.00%
|
The widely used Nitrase Therapeutics email format is {f}{last} (e.g. [email protected]) with 75.00% adoption across the company.
To contact Nitrase Therapeutics customer service number in your country click here to find.
Irene Griswold-prenner is the CEO of Nitrase Therapeutics. To contact Irene Griswold-prenner email at [email protected].
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.